Nuvation Bio, Inc. (NUVB)
NYSEHealth CareBiotechnologySnapshot 2026-09-04
$6.81+0.59%
Close 2026-09-04 · 1-day change
NYSEHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · NUVB
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 169.9 | 62.9 | 7.9 | 0.0 | — | — | — |
| Total Revenues | 169.9 | 62.9 | — | — | — | — | — |
| Cost of Revenues | — | — | 7.1 | 0.0 | — | — | — |
| Gross Profit | — | — | 0.8 | 0.0 | — | — | — |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | 158.6 | 151.6 | 69.2 | 28.5 | — | — | — |
| R&D Expenses | 128.9 | 115.1 | 99.1 | 71.3 | 87.8 | 69.0 | 32.6 |
| Operating Income | (137.6) | (213.1) | (592.6) | (99.8) | (119.7) | (93.3) | (43.6) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 13.7 | 0.3 | — | — | — | — |
| Other Non-Operating Income / Expenses | (12.2) | 8.4 | 24.7 | 24.0 | 15.5 | 6.5 | 1.9 |
| EBT, Incl. Unusual Items | (149.8) | (204.6) | (567.9) | (75.8) | (104.2) | (86.8) | (41.7) |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (149.8) | (204.6) | (567.9) | (75.8) | (104.2) | (86.8) | (41.7) |
| Per Share | |||||||
| Basic EPS | (429.59) | (0.60) | (2.11) | (0.35) | (0.48) | (0.44) | — |
| Diluted EPS | (429.59) | (0.60) | (2.11) | (0.35) | (0.48) | (0.44) | — |
| Revenue per Share | 487.14 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | — |
| Diluted Weighted Avg Shares | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | — |
| Supplemental | |||||||
| EBITDA | — | (211.3) | (591.9) | (99.6) | (119.5) | (93.1) | (43.4) |
| EBIT | (137.6) | (213.1) | (592.6) | (99.8) | (119.7) | (93.3) | (43.6) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.